Why Do We Hear More About High Drug Prices Than About Hospital Prices?
In this JAMA Health Forum post, KFF’s Larry Levitt outlines four reasons why high drug…
Why Do We Hear More About High Drug Prices Than About Hospital Prices?
In this JAMA Health Forum post, KFF’s Larry Levitt outlines four reasons why high drug prices are in the spotlight more than hospital prices, even though hospitals accounted for 40% of the growth in national health spending from 2022 to 2024, and explores the potential for policy action to restrain them.
Lilly Expands Its Mind to Psychedelics With $2.8B AtaiBeckley Acquisition
Eli Lilly’s AtaiBeckley acquisition marks a dozen M&A deals for the pharma company so far this year. AtaiBeckley’s lead program is an intranasally administered psychedelic drug in pivotal testing for treatment-resistant depression. The post Lilly Expands Its Mind to Psychedelics With $2.8B AtaiBeckley Acquisition appeared first on MedCity News.
WHO’s 2026 Cancer Report
This month, the World Health Organization (WHO) released its annual report on cancer titled Global status report on cancer 2026: the future we choose together. I provide a high level Q&A summary of see key statistics. How many cancer cases were there in 2024? “In 2024, there were 20.6 million new cancer cases worldwide5 (19.5…
What Happens to Independent Medicine When Private Equity Shows Up With a Checkbook
This is not an argument against capital in independent medicine. Practices need infrastructure, and physicians have legitimate reasons to seek liquidity. It is an argument that the exit stage carries a risk this market has not yet priced. The post What Happens to Independent Medicine When Private Equity Shows Up With a Checkbook appeared first…
A Closer Look at Deficiencies in Nursing Homes
Amid changes to federal oversight of nursing homes during the Trump administration — including rescinding the nursing home staffing rule issued by the Biden administration, prioritizing inspections that are triggered by complaints over routine inspections, and suspending the deadline to report detailed ownership information — this issue brief provides an overview of the nursing home…
GLP-1s Are Working — Now Medicine Needs to Measure What Matters
If we do not get this right, we may inadvertently cause a new sarcopenia epidemic while congratulating ourselves on solving obesity. The post GLP-1s Are Working — Now Medicine Needs to Measure What Matters appeared first on MedCity News.
Building AI-Ready Public Health Data Systems for Faster, Safer Decisions
For years, the healthcare industry treated data collection as the main challenge. The next phase is about interpretation, coordination, and operational usability. The post Building AI-Ready Public Health Data Systems for Faster, Safer Decisions appeared first on MedCity News.
A Sales Tax on Doctor Visits and Medicine? In Missouri, Some Worry
ST. LOUIS — Missouri healthcare advocate Leslie Ortbals and her husband want to start a family, but she worries they can’t afford it. The 27-year-old said she takes 10 medications daily to manage multiple chronic illnesses. Now she worries the cost of those drugs could rise — not because of price increases, but because of…
Readers Share Personal Insights on Deadly Denials and Pregnancy Centers
Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. A Tragic, Deadly Denial I read your article in The Washington Post about the woman whose Humana policy required prior authorization for a drug she’d been taking (Bill of the Month:…
KFF Health Tracking Poll: Public Views on Fraud in Government Health Programs
As the 2026 midterms approach, health care costs remain voters’ top health priority, but fraud in government health programs, including Medicaid and Medicare, is resonating with Republican voters, 55% of whom say it’s extremely important for candidates to address. Most voters say there is at least “some” fraud in government health programs, but larger shares…
